HomeXBIT • NASDAQ
add
XBiotech Inc
$2.50
Makalipas ang Oras ng Trabaho:(2.00%)+0.050
$2.55
Sarado: Hun 20, 8:00:00 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$2.60
Sakop ng araw
$2.50 - $2.68
Sakop ng taon
$2.50 - $8.32
Market cap
76.22M USD
Average na Volume
45.37K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Investor's Business Daily
1 oras ang nakalipas
U.S. Bombs 3 Iran Nuclear Sites; What Next For Markets?
0.034%
0.083%
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 13.55M | 24.85% |
Net na kita | -10.88M | -8.82% |
Net profit margin | — | — |
Kita sa bawat share | — | — |
EBITDA | -13.11M | -25.78% |
Aktuwal na % ng binabayarang buwis | -0.27% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 155.90M | -22.45% |
Kabuuang asset | 181.86M | -20.19% |
Kabuuang sagutin | 7.15M | -61.51% |
Kabuuang equity | 174.71M | — |
Natitirang share | 30.49M | — |
Presyo para makapag-book | 0.45 | — |
Return on assets | -17.78% | — |
Return on capital | -18.45% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -10.88M | -8.82% |
Cash mula sa mga operasyon | -6.72M | 6.69% |
Cash mula sa pag-invest | -94.00K | 63.14% |
Cash mula sa financing | -10.25M | -201.94% |
Net change in cash | -16.78M | -1,751.57% |
Malayang cash flow | -4.19M | 28.86% |
Tungkol
XBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases. Wikipedia
Itinatag
2005
Headquarters
Website
Mga Empleyado
90
